MEZAVANT

Serial Number 97917543
Registration 7366986
700

Registration Progress

Application Filed
May 2, 2023
Under Examination
Approved for Publication
Feb 6, 2024
Published for Opposition
Feb 6, 2024
Registered
Apr 23, 2024

Trademark Image

MEZAVANT

Basic Information

Serial Number
97917543
Registration Number
7366986
Filing Date
May 2, 2023
Registration Date
April 23, 2024
Published for Opposition
February 6, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 23, 2024
Registration
Registered
Classes
005

Rights Holder

Nogra Pharma Limited

11
Address
33 Sir John Rogerson's Quay
Dublin 2
IE

Ownership History

Nogra Pharma Limited

Original Applicant
11
Dublin IE

Nogra Pharma Limited

Owner at Publication
11
Dublin IE

Nogra Pharma Limited

Original Registrant
11
Dublin IE

Legal Representation

Attorney
Rebecca Liebowitz

USPTO Deadlines

Next Deadline
1728 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-23)
Due Date
April 23, 2030
Grace Period Ends
October 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Apr 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 6, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 6, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 30, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 14, 2023 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Dec 14, 2023 ALIE A ASSIGNED TO LIE Loading...
Jul 17, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
May 31, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 5, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases

Classification

International Classes
005